Table 8 Smoking cessation elements to be addressed in future research
From: Smoking cessation in community pharmacy practice–a clinical information needs analysis
1 | Overview of smoking–prevalence, adverse effects, benefits of quitting |
2 | Nicotine dependence–the ‘disease’ |
3 | Pharmacokinetics of nicotine |
4 | Pathophysiology of dependence |
5 | Assessment of nicotine dependence–Fagreström test, expired CO levels, urine/salive cotinine |
6 | Smoking cessation counselling–behavioural interventions, advice, support, lifestyle modifications |
7 | Smoking cessation pharmacotherapy–products, dosage forms, dosages, instructions for use, duration of therapy, adverse effects, precautions, contraindications, interactions |
8 | Debunking myths–Safety of NRT, combinations of NRT, concomitant smoking and NRT use, cut-down smoking regimens |